Cardiff Oncology, Inc. (CRDF) › Shares OutstandingCardiff Oncology, Inc. (CRDF) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 10.74M2012: 15.48M2013: 18.90M2014: 18.92M2015: 29.74M2016: 30.70M2017: 733.2K2018: 3.83M2019: 8.59M2020: 36.78M2021: 41.96M2022: 44.68M2023: 44.68M2024: 66.52M2025: 68.31M68.31M2011Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202568.31M+2.7%202466.52M+48.9%202344.68M+0.0%202244.68M+6.5%202141.96M+14.1%202036.78M+328.0%20198.59M+124.3%20183.83M+422.6%2017733.2K-97.6%201630.70M+3.2%201529.74M+57.2%201418.92M+0.1%201318.90M+22.1%201215.48M+44.2%201110.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share